Picture of Biosenic SA logo

BIOS Biosenic SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Bone Therapeutics SA Announces Final Results From Phase I/IIa Study

Sept 14 (Reuters) - BONE THERAPEUTICS SA  BOTHE.BR :
    * REG-BONE THERAPEUTICS SA ANNOUNCES FINAL RESULTS FROM
PHASE
I/IIA ALLOB DELAYED-UNION FRACTURE STUDY
    * ALL PATIENTS MET PRIMARY ENDPOINT
    * OPTIMIZED PRODUCTION PROCESS DELIVERING CRITICAL
IMPROVEMENTS
FOR FUTURE COMMERCIAL USE TO BE APPLIED TO ALL ALLOGENEIC
PLATFORM CLINICAL TRIALS

Source text for Eikon:  ID:nGNE4mlwj5 
Further company coverage:  BOTHE.BR 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))

Recent news on Biosenic SA

See all news